The study of tentative therapeutic methods targeting IL-27/IL-27RA/Wnt or SFRP2 is of great research significance in investigating trophoblast-related diseases, such as FGR, preeclampsia, miscarriage and so on. Here, SFRP2 is linked to preeclampsia.